FATE
Fate Therapeutics Inc
2.30$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.8% | +14.9% | +251.8% | -54.6% | -39.5% | -12.4% | +17.1% | -8.7% | -21.4% | -5.1% | +60.3% | – | |
| – | +3.1% | -1.3% | -2.1% | +634.0% | -50.5% | +70.0% | -86.9% | +576.2% | -88.1% | -4.7% | – | – | |
| – | – | – | – | -1,639.5% | – | – | – | – | – | -218.3% | – | – | |
| – | -7.2% | +1.0% | +7.7% | +0.1% | -3.0% | -13.3% | -5.9% | -5.8% | -1.6% | -14.3% | +11.9% | – | |
| – | -5.3% | +16.3% | -17.3% | +20.6% | -26.6% | -9.8% | -16.9% | -7.1% | +0.3% | -10.0% | -8.0% | – | |
| – | -7.5% | +7.4% | -2.2% | -55.9% | +123.4% | -70.4% | +154.5% | -69.7% | +239.3% | -13.0% | +5.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -74.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.